Recombinant DNA research; actions under guidelines; notice -- E. Points to consider for protocols for the transfer of recombinant DNA into the genome of human subjects.
D026683:Advisory Committees; D003256:Community Participation; D003219:Confidentiality; D004274:DNA, Recombinant; D030881:Disclosure; D017041:Ethics Committees; D028744:Ethics Committees, Research; D035082:Federal Government; D015316:Genetic Therapy; D006076:Government; D033161:Government Regulation; D017408:Guidelines as Topic; D015386:Hazardous Substances; D006805:Human Experimentation; D006801:Humans; D033181:Information Dissemination; D007255:Information Services; D007258:Informed Consent; D009316:National Institutes of Health (U.S.); D018579:Patient Selection; D010361:Patients; D011361:Professional Competence; D011640:Public Policy; D012015:Reference Standards; D012107:Research Design; D012108:Research Personnel; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D014481:United States
Biomedical and Behavioral Research; Genetics and Reproduction; Human Gene Therapy Subcommittee; Legal Approach; NIH Guidelines; National Institutes of Health; Points to Consider: Transfer of Recombinant DNA into Human Subjects; Recombinant DNA Advisory Committee